top of page
VitraGel Matrix
TM
Enabling ethical drug development
DID YOU KNOW?
Over
90%
of drug candidates fail because...
…traditional cell culture does not predict human drug responses
…animals experiments rarely predict human biology
…existing 3D cell culture products are unsuitable for drug development
This causes:
-
Up to US $2 Billion in financial losses per unsuccessful drug candidate
-
Impact on animal welfare (> 200 million animals euthanised/year)
-
Significantly delayed time-to-market
-
Increased development costs
-
Inefficient use of resources
-
Reduced public trust and reputation
The Solution
Growing human tissues for drug testing
VitraGel Matrix
Allows generation of
human tissues
in a petri dish
Better predicts human drug responses
Reduces need for animal experiments
Reduces drug development costs
Improves R&D process efficiency
Accelerates drug development
Huge
Market Opportunities
3D Cell Culture Market
TAM 2024: US$2.1 billion
SAM 2024: US$770 million
Targeted Market Percentage: 10%
Drug Development Technologies Market
TAM 2024: US$95.3 billion
SAM 2024: US$956 million
Targeted Market Percentage: 5%
3D Bioprinting Market
TAM 2024: US$3.9 billion
SAM 2024: US$246 million
Targeted Market Percentage: 10%
Join us in creating a better world by eliminating the need for animal testing
bottom of page